Table 4 Reasons for ustekinumab discontinuation throughout the study period
Motive | N (%) |
|---|---|
Lack of response/disease progression (with or without surgery) | 17 (38.6) |
Non-primary response (with or without surgery) | 12 (27.3) |
Lack of access/reimbursement | 7 (15.9) |
Pregnancy | 6 (13.6) |
Depression and treatment abandonment | 2 (4.6) |
Total | 44 (100.0) |